Revvity Total Assets 2010-2024 | RVTY

Revvity total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Revvity total assets for the quarter ending September 30, 2024 were $13.425B, a 5.58% decline year-over-year.
  • Revvity total assets for 2023 were $13.565B, a 4% decline from 2022.
  • Revvity total assets for 2022 were $14.13B, a 5.8% decline from 2021.
  • Revvity total assets for 2021 were $15.001B, a 88.44% increase from 2020.
Revvity Annual Total Assets
(Millions of US $)
2023 $13,565
2022 $14,130
2021 $15,001
2020 $7,960
2019 $6,539
2018 $5,976
2017 $6,091
2016 $4,277
2015 $4,166
2014 $4,128
2013 $3,947
2012 $3,902
2011 $3,856
2010 $3,209
2009 $3,059
Revvity Quarterly Total Assets
(Millions of US $)
2024-06-30 $13,425
2024-03-31 $13,433
2023-12-31 $13,565
2023-09-30 $13,422
2023-06-30 $14,219
2023-03-31 $14,638
2022-12-31 $14,130
2022-09-30 $13,824
2022-06-30 $14,190
2022-03-31 $14,848
2021-12-31 $15,001
2021-09-30 $14,900
2021-06-30 $8,739
2021-03-31 $8,763
2020-12-31 $7,960
2020-09-30 $6,866
2020-06-30 $6,637
2020-03-31 $6,384
2019-12-31 $6,539
2019-09-30 $6,489
2019-06-30 $6,399
2019-03-31 $6,086
2018-12-31 $5,976
2018-09-30 $5,862
2018-06-30 $5,958
2018-03-31 $6,126
2017-12-31 $6,091
2017-09-30 $4,739
2017-06-30 $4,605
2017-03-31 $4,341
2016-12-31 $4,277
2016-09-30 $4,305
2016-06-30 $4,194
2016-03-31 $4,211
2015-12-31 $4,166
2015-09-30 $4,032
2015-06-30 $4,083
2015-03-31 $4,028
2014-12-31 $4,128
2014-09-30 $3,886
2014-06-30 $3,937
2014-03-31 $3,971
2013-12-31 $3,947
2013-09-30 $3,852
2013-06-30 $3,811
2013-03-31 $3,808
2012-12-31 $3,902
2012-09-30 $3,890
2012-06-30 $3,801
2012-03-31 $3,864
2011-12-31 $3,856
2011-09-30 $3,402
2011-06-30 $3,596
2011-03-31 $3,306
2010-12-31 $3,209
2010-09-30 $3,248
2010-06-30 $3,146
2010-03-31 $3,027
2009-12-31 $3,059
2009-09-30 $3,059
2009-06-30 $2,946
2009-03-31 $2,858
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00